Traumatic brain injury (TBI) contributes to over 30% of injury-related deaths and is a major cause of disability without effective clinical therapies. Oxidative stress contributes to neurodegeneration, neuroinflammation, and neuronal death to amplify the primary injury after TBI. NADPH oxidase (NOX) is a major source of reactive oxygen species following brain injury. Our current study addresses the functional role of the NOX4 isoform in the damaged cortex following TBI. Adult male C57BL/6 J and NOX4 -/-mice received a controlled cortical impact and lesion size, NOX4 expression, oxidative stress, neurodegeneration, and cell death were assessed in the injured cerebral cortex. The results revealed that NOX4 mRNA and protein expression were significantly upregulated at 1-7 days post-TBI in the injured cerebral cortex. Expression of the oxidative stress markers, 8-OHdG, 4-HNE, and nitrotyrosine was upregulated at 2 and 4 days post-TBI in the WT injured cerebral cortex, and nitrotyrosine primarily colocalized with neurons. In the NOX4 -/-mice, expression of these oxidative stress markers, 8-OHdG, 4-HNE, and nitrotyrosine were significantly attenuated at both timepoints. In addition, examination of NOX4 -/-mice revealed a reduced number of apoptotic (TUNEL + ) and degenerating (FJB + ) cells in the perilesional cortex after TBI, as well as a smaller lesion size compared with the WT group. The results of this study implicate a functional role for NOX4 in TBI induced oxidative damage and neurodegeneration and raise the possibility that targeting NOX4 may have therapeutic efficacy in TBI.
Introduction
A leading cause of death and disability in young adults in the United States, traumatic brain injury (TBI) accounts for approximately 2.5 million emergency department visits and has gained recognition as a chronic and progressive disorder that results from an acute trauma [1] [2] [3] [4] [5] . The heterogeneity of clinical TBI and complexity of secondary injury mechanisms pose an unmet challenge in translating effective neuroprotective strategies [6] [7] [8] . This secondary injury, which evolves over minutes to years after the primary mechanical injury, develops as a result of complex biochemical cascades involving oxidative stress, neuroinflammation, edema, and cell death [9] [10] [11] [12] [13] .
Oxidative stress is a major mediator of the secondary injury that follows TBI [5, [14] [15] [16] . Along these lines, reactive oxygen species (ROS), such as superoxide and hydroxyl radicals, can significantly impact severity, lesion size, and progression of TBI [17] . In low to moderate levels, ROS can function physiologically in cell growth and signaling [18] , but pathological conditions can quickly shift in favor of oxidants [19] . Adding to the complexity of the oxidant/antioxidant balance, superoxide, in particular, can act as either a reductant or an oxidant and has been suggested to both initiate and terminate lipid peroxidation [20] [21] [22] . Many enzymes produce ROS in the cell, but NADPH oxidase (NOX) is the only family of enzymes with the sole purpose of producing ROS, instead of as a byproduct [23] . Thus, targeted inhibition of NOX family members may limit secondary injury after TBI. To date, there are seven known NOX isoforms: NOX1-5 and DUOX1/2. These isoforms are structurally similar in that all are anchored to the cell membrane via 6 transmembrane α-helices, and all have binding sites for heme, flavin adenine dinucleotide, and NADPH [24, 25] . Although NOX serves essential physiological functions in signaling and immune function [26] , chronic and over-activation can be detrimental to injury resolution [4] . In post-mortem human brain samples, elevated NOX2 and NOX4 both correlate with TBI severity [27, 28] . Pre-clinical studies by our lab and others strongly support an acute detrimental role for NOX2 after TBI, including data showing genetic or pharmacological NOX2 inhibition attenuated inflammation, oxidative stress, and expression of markers indicative of Alzheimers-like pathology [4, 5, [29] [30] [31] [32] [33] [34] [35] ; however, the functional importance for NOX4 remains unexplored after TBI.
NOX4 generates superoxide like the other NOX isoforms, yet the downstream effects are thought to be mediated by hydrogen peroxide due to the rapid conversion of NOX4-generated superoxide to hydrogen peroxide [36, 37] . Inhibition of NOX4 reduced injury in an ischemic stroke model [38, 39] , yet, few studies examined the pathological role of NOX4 after TBI. NOX4 immunoreactivity was increased in the cortex of rats after TBI and in postmortem human brain samples obtained from athletes diagnosed with chronic traumatic encephalopathy [5, 28, 30] , but causative studies to establish the role of NOX4 are lacking after TBI.
The primary goal of the current study was to determine whether NOX4 contributes to secondary injury following TBI. Our results revealed a robust increase in NOX4 expression within the injured mouse cerebral cortex, paralleling increased oxidative stress following TBI. Deletion of NOX4 strongly attenuated neuronal oxidative stress, lesion severity, apoptosis, and neurodegeneration following TBI. Taken together, our study supports a deleterious role for NOX4 after TBI, Representative Western blot showing temporal protein expression of NOX4 in the perilesional cortex at 1, 4, and 7 dpi. BV2 sample included as positive control for NOX4. β-actin blot used for densitometry. (C) Quantification of all blots shows increased protein expression of NOX4 at 1, 4, and 7d post-TBI compared to sham group. NOX4 band densities were normalized to densities of β-actin. n = 7, 4, 9, 6 mice (sham, 1d, 4d, 7d, respectively). Values expressed as mean ± SEM. *p < .05, **p < .01, ***p < .001, ****p < .0001 sham vs TBI timepoint. Fig. 2 . NOX4 immunoreactivity colocalizes in neurons in the injured cerebral cortex. Representative confocal images showing immunoreactivity of injured cortex to NOX4 (red) and NeuN (green). Nuclei stained with DAPI (blue). Line-scan analysis on a representative NOX4 + cell in each group showed a strong overlap of the NOX4 intensity peak with the NeuN intensity peak, indicating strong colocalization. Representative image and line scan from injured NOX4 -/-mice show a virtually nonexistent level of NOX4 intensity that does not overlap with NeuN intensity peak. Scale bar = 50 µm; n = 4-5 mice/group. [66] [67] [68] [69] [70] [71] [72] [73] [74] [75] suggesting the development of NOX4 selective inhibitors may represent potential drugs target for the clinical treatment of TBI.
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Materials and methods
Animals
Adult male 3-month old WT C57BL/6 J (stock no. 000664) and NOX4 -/-(B6.129-Nox4 tm1Kkr /J; stock no. 022996) mice obtained from Jackson Lab (Bar Harbor, ME) were used in this study. Mice were placed in the same room for at least 72 h before experiments and were housed under humidity and temperature controlled conditions with free access to food and water. All animal experiments were approved by the Augusta Charlie Norwood VA Medical Center Institutional Animal Care and Use Committee.
Controlled cortical impact
Controlled cortical impact (CCI) or sham surgery was performed on WT and NOX4 -/-mice under an approved animal use protocol. Mice were anesthetized with isoflurane (2-4%) and placed in a stereotaxic frame (Leica Impact One™ Stereotaxic Impactor for CCI, Buffalo Grove, IL, USA) for CCI or sham surgery as detailed previously by our laboratory [33] [34] [35] 40] . A 3.5 mm craniotomy was made in the right parietal bone midway between the lambda and the bregma with the medial edge 1 mm lateral from the midline. The dura was left intact. TBI mice, but not shams, were impacted using a 3 mm diameter convex tip (4.5 m/s, 20 ms dwell time, 1 mm depression) to produce a moderate TBI. Bone wax covered the cranial window following impact, and surgical staples closed the scalp incision. Mice were allowed to recover before being placed back into their housing environment. Body temperature was monitored and maintained at 37°C using a small thermometer (Kopf Instruments, Tujunga, CA, USA) throughout the operation. Sham operated mice received identical treatment except for the impact.
Tissue collection
All animals were transcardially perfused with ice-cold saline and decapitated after TBI at specified timepoints. For RT-PCR and Western blot analysis, the brains were then dissected and processed as described in subsequent sections. For coronal sections to be used for immunohistochemistry, mice were transcardially perfused with saline followed by 4% paraformaldehyde before decapitation. The brains were removed, fixed overnight in 4% paraformaldehyde, cryoprotected in 30% sucrose, and sectioned into 20 μM coronal slices on the cryostat for further staining.
qRT-PCR
Total RNA was isolated from the injured cortex (or an anatomically matched cortical area on sham mice) using the SV Total RNA Isolation System (Promega). Perilesional cortical tissue averaging 50-60 mg per mouse was collected at specified time points after TBI. 400 ng of RNA was used for quantitative reverse-transcription polymerase chain reaction (RT-PCR) using the Superscript III one-step RT-PCR system with platinum Taq DNA Polymerase (Invitrogen). The reaction was performed on QuantStudioTM 7 Flex Real-Time PCR System (ThermoFisher Scientific). Gene expression analyses were done using the comparative ΔΔCt method and mRNA changes were expressed as fold change as compared to sham animals by calculating the 2 -ΔΔCt value. 18 S was used as the housekeeping gene for normalization. Primers (Integrated DNA Technologies) used are as follows (5′ to 3′): NOX4 (FP: AAAAATATCACACACTGAATTCGAGACT, RP: TGGGTCCACAGCAGAAAACTC) and 18 S (FP: TTGACGGAAGGGCACC ACCAG, RP: CTCCTTAATGT CACGCACGATTTC).
Western blot analysis
50-60 mg of injured cortical tissue from the perilesional area (or an anatomically matched cortical area on sham mice) were collected at specified time points after TBI as previously described by our laboratory [33] [34] [35] . The isolated tissue was immediately frozen in liquid nitrogen or kept on ice for immediate homogenization in ice-cold RIPA buffer (50 mM Tris-HCl pH 7.4, 150 mM NaCl, 1% Triton X-100, 1% sodium deoxycholate, 0.1% SDS, 1 mM EDTA; with Roche cOmplete protease inhibitor and PhosphoSTOP) with a tissue tearor. The homogenate was centrifuged at 12,000 RPM for 20 min at 4°C, and the supernatant was aliquoted for further analysis. A BCA Protein Assay (Thermo Fisher Scientific, Carlsbad, CA) was used to determine protein concentrations. 20 μg samples of protein was separated on a 4-20% SDS-PAGE gel and transferred onto 0.2 μM nitrocellulose membranes. Blots were blocked with 5% nonfat milk for 1 h at room temperature with gentle shaking. After blocking, the blots were incubated overnight in 4°C with a NOX4 [66] [67] [68] [69] [70] [71] [72] [73] [74] [75] primary antibody (1:1000, Abcam, ab109225). β-actin (1:4000, Sigma Aldrich, A5441) was used as a loading control. The membrane was then washed with 1× TBST, and then incubated with secondary antibodies. Bound proteins were visualized using enhanced chemiluminescence (ECL), and band densities were quantified using Image Studio (LI-COR, Inc.).
Confocal microscopy and image analysis
Three to four coronal sections from each mouse (every tenth slice between −1.46 mm and −2.18 mm from bregma) were washed with PBS and permeabilized with 0.4% Triton-X PBS for 20 min. The sections were then blocked with 10% normal donkey serum for 1 h at room temperature in 0.1% Triton X-100-PBS. Sections were incubated for 2 nights with primary antibody at 4°C in the same buffer using the following antibodies: NOX4 (rabbit, 1:200, Abcam, ab109225), NeuN (mouse, 1:200, Millipore Sigma, MAB377), NeuN (rabbit, 1:200, Millipore Sigma, MABN140), 4-HNE (rabbit, 1:100; Abcam, ab46545), 8-OHdG (mouse, 1:100, Abcam, ab62623), and 3-NT (mouse, 1:50, Santa-Cruz, sc-32731). After primary antibody incubation, the sections were washed in PBS and incubated for 1 h at room temperature with secondary antibodies (1:500, Alexa Fluor 488/568). Sections were then mounted with water-based DAPI mounting medium containing antifading agents (Vector Labs, H-1200) and observed using confocal microscopy. All images were captured on a Carl Zeiss 780 confocal microscope at 40× Plan-Apochromat objective with constant exposure time for each marker in all analyzed sections. When applicable, linescan analysis was performed on representative confocal microscopy images using Zeiss LSM software to qualitatively visualize fluorescence overlap. The intensity above threshold of the fluorescent signal of the bound antibodies was analyzed using NIH ImageJ software. Data were expressed as fold change from sham.
Lesion size and neuronal survival quantification
A total of 60 coronal sections were collected between −0.82 mm and −2.54 mm from bregma. 6 sections from each animal, at even 8 section intervals, were stained with cresyl violet and analyzed for lesion size. As previously described [33, 41, 42] , lesion area was outlined using ImageJ freeform selection tool and quantified as a percent of the contralateral hemisphere. NeuN + cells were counted using a method similar to that previously reported [33, 43] . %NeuN + cells were calculated as (# of NeuN + cells)/(# of DAPI + cells) in a consistent and set area in the perilesional cortex using 40× confocal images. Set linear threshold and circularity index were kept as constant parameters across all analyzed images in ImageJ for automated cell counting. The percentages of %NeuN + cells were reported relative to that of sham mice.
At least 3 sections from 4 mice per experimental group were examined for quantification of neuronal survival.
Apoptosis and neurodegeneration assessment
Apoptosis was assessed via terminal deoxynucleotidyl transferase dUTP nick end labeling (TUNEL). The above prepared coronal brain sections were labeled with a TUNEL kit (Click-iT TUNEL Alexa Fluor 594, Thermo Fisher, C10246) following their protocol for fixed, frozen tissue sections using a dark, humidified chamber as previously described [34, 44] . Images were analyzed using confocal microscopy for TUNEL + cells, which were quantified as a percent of total DAPI + cells per microscope field. At least 3 sections from each mouse were stained for quantification. Neurodegeneration was assessed via FluoroJade B staining using a method as previously detailed by our lab [45] . Coronal sections were incubated in the dark for 20 min with fluorescent FluoroJade B stain diluted in PBS as recommended by the manufacturer (Millipore Sigma, AG310). Following incubation, sections were washed with PBS-Triton X-100, PBS, and dH 2 O. Sections were mounted using water-based mounting medium containing antifading agents and visualized to quantify degenerating neurons. FJB + cells per microscope field were counted; at least 3 sections from each mouse were stained for quantification. Images were acquired using Keyence Fluorescence Microscope BZ-X700 at 40× magnification.
Statistical analysis
Independent two-sample t-test was conducted to investigate difference between lesion sizes of WT vs NOX4 -/-TBI mice. The one-way
ANOVA test was conducted to analyze differences amongst sham, WT TBI, and NOX4 -/-TBI mice in knockout studies and amongst the different time points following TBI in time course studies. Whenever an ANOVA test was found to be significant, the post-hoc Tukey's test was conducted to make pairwise comparisons between experimental groups. Statistical significance was accepted at the 95% confidence level (p < .05) using GraphPad Prism. Data was expressed as mean ± standard error (SEM).
Results
Increased expression of NOX4 in the injured cortex following TBI
To determine a role of NOX4 in TBI pathology, we measured expression of the Nox4 gene at the mRNA level after injury. We collected perilesional cortical tissue from WT mice at 1hr, 1d, 2d, 4d, 7d, and 14d post TBI for use in quantitative real time-PCR (qRT-PCR) studies. Nox4 mRNA was significantly upregulated between 1 and 7 days post-injury (dpi), returning to baseline by 14 dpi (Fig. 1A) . To confirm our findings, we evaluated the protein level of NOX4 using samples from a separate cohort of WT mice at 1, 4, and 7 dpi. Consistent with the qRT-PCR result, Western blot showed elevated NOX4 protein expression at 1, 4, and 7 dpi (Fig. 1B and C) . Immunohistochemistry and confocal microscopy detected that the elevated immunoreactivity of NOX4 was predominantly located in neurons in the injured cerebral cortex at 4 dpi (Fig. 2) . This observation is supported by line-scan analysis on the channel intensity of NeuN, NOX4, and DAPI, which showed strongly overlapping NeuN (green) and NOX4 (red) intensity peaks. Line-scan of NOX4 -/-injured mice at 4 dpi showed essentially nonexistent NOX4
intensities that did not overlap with the NeuN intensity peak, which demonstrate that increased NOX4 was not seen in NOX4 -/-mice (Fig. 2) .
NOX4 -/-mice have reduced lesion size following TBI
Previous work has shown that the degree of cell loss after brain injury correlates with long-term TBI prognosis, and the preservation of neurons within intact brain tissue can be important indicators of outcomes [34, [46] [47] [48] [49] . Therefore, we first subjected WT and NOX4 -/-mice to TBI and collected brain samples at 4 dpi to generate a series of coronal sections spanning the entire lesion. Sections were stained with cresyl violet, and lesion size was measured as area of contralateral cortex for each section. Compared to WT mice, NOX4 -/-mice showed a significant reduction in lesion size at 4 dpi (Fig. 3) . This result supports that NOX4 -/-mice have better preservation of brain tissue following TBI Fig. 4 . Deletion of NOX4 attenuates oxidative stress in the injured cerebral cortex. Representative confocal images showing immunoreactivity of the injured cortex to 4-HNE (red) and 8-OHdG (green) in sham and injured mice at 2 and 4 dpi. Nuclei stained with DAPI (blue). TBI increases tissue immunoreactivity to 4-HNE and 8-OHdG in the injured cortex at both 2 and 4 dpi, with more pronounced expression and colocalization of 4-HNE and 8-OHdG at 4 dpi. NOX4 -/-mice showed attenuated tissue immunoreactivity to 4-HNE and 8-OHdG at both 2 and 4 dpi.
Scale bar = 50 µm. All confocal images quantified as intensity over threshold in graphs below representative panel, represented as fold change relative to sham mice; n = 5 mice/group/ timepoint. Values expressed as mean ± SEM. *p < .05, **p < .01, ***p < .001, ****p < .0001 sham vs WT TBI; #p < .05, ##p < .01, ###p < .001 WT TBI vs NOX4 -/-TBI. [66] [67] [68] [69] [70] [71] [72] [73] [74] [75] and that deletion of NOX4 may be neuroprotective.
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Deletion of NOX4 attenuates oxidative stress in the injured cortex following TBI
Cellular oxidative stress damage contributes to secondary injury after TBI [5, 14, 50] . In particular, previous reports indicate that TBI can cause peroxidative and nitrative damage within the first week following injury that is functionally deleterious [51, 52] . Therefore, we hypothesized that the reduced lesion size observed in NOX4 -/-mice following injury may be due to reduction of oxidative stress damage. To measure oxidative damage following TBI, products of oxidative stress such as 4-hydroxynonenal (4-HNE) from lipid peroxidation and 8-hydroxy-2′-deoxyguanosine (8-OHdG) from DNA oxidation were measured via immunostaining in the damaged cortex at 2 and 4 dpi (Fig. 4A) . The fluorescence intensity above threshold of 4-HNE and 8-OHdG were quantified in the perilesional cortex and compared between sham, WT TBI, and NOX4 -/-TBI group (Fig. 4B and C) . At both 2 and 4 dpi, TBI significantly increased the intensity of 4-HNE and 8-OHdG within the injured cortex, compared to sham controls, with the 4 dpi group (Fig. 4C ) showing higher expression of these oxidative stress markers than the 2 dpi group (Fig. 4B) . Deletion of NOX4 markedly reduces the intensity of 4-HNE and 8-OHdG in the perilesional cortex (Fig. 4A-C) . Although a similar trend of increasing oxidative stress from 2 to 4 dpi persists in the NOX4 -/-injured mice, levels of these oxidative stress markers at both timepoints remain significantly lower than that of WT ( Fig. 4B and C) . These results support that deletion of NOX4 reduces oxidative stress following TBI. Our previous NOX4 expression pattern suggests that NOX4 activation following TBI may be primarily neuronal. We next sought to measure oxidative damage of neurons after TBI by co-immunostaining 4-HNE with NeuN in the perilesional cortex following TBI. Confocal microscopy found that the elevated 4-HNE expression co-localized with NeuN at both 2 and 4 dpi in WT mice (Fig. 5) . Line scan analyses on the [66] [67] [68] [69] [70] [71] [72] [73] [74] [75] fluorescence intensity peaks at both 2 and 4 dpi showed a strong overlap of 4-HNE (red) with NeuN (green) in WT, but not in NOX4
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-/-injured mice (Fig. 5) . These results support an increase in neuronal oxidative stress following TBI, which is attenuated with deletion of NOX4. Furthermore, we measured nitrotyrosine (3-NT) following injury as an indicator of post-translational oxidative damage. Excess levels of ROS produced in the presence of nitric oxide can lead to formation of nitrating species that can nitrate protein tyrosine residues to 3-NT [53] . WT injured mice showed significantly elevated 3-NT expression in the perilesional cortex following TBI and had strong overlap of 3-NT (green) and NeuN (red) intensity peaks ( Fig. 6A and B) , supporting that TBI increased tyrosine nitration which could be seen in neurons. However, 3-NT expression was attenuated in the perilesional cortex of NOX4 -/-and line-scan analyses did not show strong colocalization of 3-NT with NeuN. These results, coupled with earlier findings of reduced DNA oxidation and lipid peroxidation, suggest that deletion of NOX4 can also attenuate neuronal nitroxidative stress following TBI.
NOX4 deletion is neuroprotective following TBI
The reduction in oxidative stress products following TBI in NOX4 -/-mice also correlated with an increase in neuronal survival. NeuN + cell counts normalized to total DAPI + cell counts showed significant reduction in surviving neurons following TBI (Fig. 6C) . Neuronal counts from NOX4 -/-injured mice are similar to those of sham mice (Fig. 6C) , which suggest that deletion of NOX4 may increase neuronal survival following TBI. To evaluate further the neuroprotective effect of NOX4 deletion, we measured apoptosis in the injured cortex following TBI via TUNEL staining. The number of TUNEL + cells (red) is significantly increased at both 2 and 4 dpi in WT mice compared to sham controls ( Fig. 7A and B) . Compared to the WT group, NOX4 -/-injured mice showed a significant reduction in TUNEL + cells at both timepoints ( Fig. 7A and B) . As growing evidence supports that TBI contributes to neurodegeneration [54] , we next evaluated whether acute neurodegeneration may be reduced via NOX4 deletion after TBI. To evaluate the extent of neurodegeneration in the perilesional cortex following TBI, we used Fluoro-Jade B, a specific fluorescent dye that can label degenerating neurons [55] . At 4 dpi, WT mice showed elevated FJB + cells (green) in the injured cortex ( Fig. 7C and D) . NOX4 -/-injured mice showed markedly reduced FJB + cell counts ( Fig. 7C and D) . Taken together, these results support that deletion of NOX4 is neuroprotective by promoting neuronal survival, reducing apoptosis, and attenuating neurodegeneration following TBI.
Discussion
Increasing evidence shows that excess ROS generation and accompanying oxidative stress is critical in the pathological progression of acute brain injuries, such as TBI and stroke, and in chronic neurodegenerative disorders [5, 56] . In particular, NADPH oxidase family of enzymes have emerged as key contributors to TBI pathology, and the number of studies suggesting NOX enzymes for therapeutic targeting are continually increasing [5, 14, [31] [32] [33] [34] [35] 57, 58] . The findings in the current study suggest that NOX4-mediated oxidative stress leads to a more severe consequences following TBI. In this report, we show that NOX4 expression increases following focal TBI in mice and that this increase in NOX4 expression is accompanied by elevated oxidative stress and cell death. We further report that deletion of NOX4 attenuates TBI severity as measured via reduction of lesion size, oxidative stress damage, neurodegeneration, and cell death. These neuroprotective effects seen in NOX4 -/-injured mice support the further study of NOX targeting for TBI treatment.
Our results contribute to the growing evidence surrounding the targeting of ROS generating enzymes to ameliorate the course of brain injury and neurodegenerative diseases [5] . Previous animal studies of promising ROS scavengers and ROS degrading agents in stroke failed to translate successfully in clinical trials, and it is still unclear whether the scavenging approach will meet the same fate in TBI [59] [60] [61] [62] [63] . Targeting the generation of ROS may be a more successful avenue of therapy for brain injury [5] . For TBI, in particular, the NOX inhibitors, apocynin and gp91ds-tat, can improve outcomes following experimental TBI, keeping with reports showing NOX knockout mice similarly improve outcomes [29] [30] [31] [32] [33] [34] [35] 64] . The majority of these studies demonstrate a role for the NOX2 isoform in TBI. NOX4 plays a role in stroke pathology and can be targeted to reduce ischemic injury [38, 39] . NOX4 appears to be involved in TBI pathology [27, 28, 30] , and nonspecific NOX inhibition by apocynin in the previous studies may have targeted NOX4 in addition to other isoforms. To date, no NOX4 specific inhibitors exist to test the functional role of NOX4 in TBI. Our report is the first to utilize NOX4 -/-mice in a clinically relevant model of TBI to elucidate a direct and significant role of NOX4 in TBI pathology. Our findings support the need for continued pursuit to develop NOX4-specific inhibitors, and for further study of NOX4 as a therapeutic target for TBI. While other NOX isoforms potentially play a role in TBI [30] , the majority of studies to date focused on the role of NOX2 in mediating neuroinflammation and oxidative stress after TBI [4, 31, [33] [34] [35] 65] . However, targeting of NOX4 may be advantageous if efficacious in the context of TBI. Hospitalized TBI patients are at a higher risk of nosocomial infections with an infection-related mortality rate up to 28% [66] [67] [68] [69] . First studied as part of the respiratory burst of phagocytes, NOX2 is known to play important roles in the body's immune defense [70] [71] [72] . NOX2 deficiency is also closely involved in the pathogenesis of chronic granulomatous disease (CGD), an inherited disorder characterized by recurrent infections that originate from defects in innate immunity, and NOX2 -/-mice are frequently utilized as models of CGD [73] [74] [75] . Taking into consideration the increased risk of infection, it's possible that NOX2 targeting may worsen susceptibility to infections post-hospitalization for TBI though further studies are necessary to evaluate this potential disadvantage. In contrast, NOX4 -/-mice are generally healthy with no gross phenotypes [38, 76] . Differences in cellular expression patterns between NOX2 and NOX4 can also influence isoform preference in therapeutic inhibition. While NOX4 is expressed in multiple cell types in the brain [5, 30] , our cellular localization results in this study indicate a primarily neuronal expression in the acute phase following TBI. Previous reports have demonstrated strong microglial expression of NOX2 at similar timepoints [30, 31, 34, 58] and demonstrated NOX2 involvement in neuroinflammation [33] . Furthermore, a recent study showed that depletion of microglia in the acute phase exacerbates inflammation and brain injury [77] . However, activated microglia are chronically present in the injured brain and is correlated with progressive neurodegeneration [4] . A growing body of evidence suggests that microglia and neuroinflammation following TBI has both a beneficial and deleterious role and that therapeutically guided modulation of inflammation may be advantageous over global inhibition [78] [79] [80] . Based on cellular expression, acute NOX4 inhibition may reduce neuronal oxidative damage without significant hindrance of acute inflammatory functions of microglia that mostly express and mediate inflammation via NOX2. Targeting NOX4 may therefore be a promising therapy for TBI to reduce oxidative damage while maintaining acute immune function pending further evaluations utilizing NOX4 specific inhibitors. With the failure of past clinical trials, there is an undeniable need for effective clinical therapies for neuroprotection following TBI. NOX4 is a novel therapeutic target that can potentially reduce acute oxidative injury and maintain beneficial inflammation without the likely immunosuppressive effects of NOX2 inhibition. We have demonstrated that NOX4 is a significant component of TBI pathophysiology. The genetic deletion of NOX4 can attenuate oxidative stress, lesion severity, cell death, and neurodegeneration found following focal TBI. Further studies with pharmacological inhibitors specific for NOX4 as they become available are necessary to determine whether NOX4 can be therapeutically targeted post-injury during the critical window following TBI.
